Treatment of essential hypertension with PN 200-110 (isradipine)

Singh, 1978, Verapamil: a review of its pharmacological properties and therapeutic use, Drugs, 15, 169, 10.2165/00003495-197815030-00001 Hugenholtz, 1981, Nifedipine in the treatment of unstable angina, coronary spasm and myocardiaJ ischemia, Am J Cardiol, 47, 163, 10.1016/0002-9149(81)90305-2 Koiwaya, 1981, Increased exercise tolerance after oral diltiazem, a calcium antagonist, in angina pectoris, Am Heart J, 101, 143, 10.1016/0002-8703(81)90656-6 Massie, 1984, Calcium channel blockers as antihypertensive agents, Am J Med, 77, 135, 10.1016/S0002-9343(84)80049-2 Halperin, 1986, The role of calcium channel blockers in the treatment of hypertension, Am Heart J, 111, 363, 10.1016/0002-8703(86)90154-7 Data on File, Pharmaceutical Division, Sandoz, Inc., East Hanover, New Jersey. Leonetti, 1982, Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects, J Cardiovasc Pharmacol, 4, S319 Leonetti, 1981, A double-blind comparison of the antihypertensive effects of verapamil and propranolol, 260 Nicholson, 1983, The hypotensive effect of calcium channel blockade with verapamil is enhanced by increased dietary sodium intake (abstr), Clin Res, 31, 334A DeMarinis, 1980, Culcium antagonists and hormone release. I. Effects of verapamil on insulin release in normal subjects and patients with islet-cell tumor, Metabolism, 29, 599, 10.1016/0026-0495(80)90103-1